Corporate Office


Facility Location


Facility Size


Projected Capacity

537,500 KG/ANNUM

Asterion Cannabis Inc. is a Canadian medicinal cannabis company with a wholly-owned Australian subsidiary, Asterion (Australia) Pty Ltd. With its cultivation to market strategy, the company's focus is leading and advancing cannabis agriculture, producing the highest quality, low cost, genetically uniform cannabis strains and cannabinoid products for global supply. The Australian government formally recognizes the company with a Major Project Status and the company has been granted a medicinal cannabis license, a cannabis research license, and a manufacture license from the Australian Office of Drug Control.

Led by a highly experienced team with over 200 years of combined relevant credentials spanning – North America, Europe, the Middle East, and Asia-Pacific. Management experience with large scale projects includes medicinal cannabis, renewable energy, and capital markets.

  • Finance
  • Corporate Relations
  • International Business Development
  • Pharmaceuticals
  • Nutraceuticals
  • Preventive Health
  • Cannabis/Hemp
  • Commercialization
  • Natural Resources
  • Renewable Energy
  • Industrial Development
  • Multi-Jurisdiction Exporting
  • Hi-Tech Horticulture
  • State-of-the-Art R&D
November 18, 2020

Asterion Enters into Contractual Agreement with BESIX Watpac

arrowRead More
August 27, 2020

Asterion Receives Sativa Seeds for its Tissue Culture Program

arrowRead More
August 25, 2020

Asterion Warrants Expiring October 1, 2020

arrowRead More

arrowView All News

Stay up to date with our latest news:

What are you searching for?

Stay up to date with our latest news:

Sign up to receive updates
Are you of legal age in your province or territory of residence?